Inventor · disambiguated record
Herren Wu
Also filed as: WU HERREN
50 granted patents·57 pending applications·1,533 citations·filing 1999–2024
99Inventor score
Top patents by PatentIndex Score
107 records- 0199US7658921B2Molecules with extended half-lives, compositions and uses thereofMEDIMMUNE LLC·Filed 2007·Granted Feb 9, 2010·185 cites·14 claims
- 0298US8409568B2Mutant antibody Fc domains and fusion proteins thereofGAO CHANGSHOU·Filed 2010·Granted Apr 2, 2013·97 cites·12 claims
- 0398US7553489B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2006·Granted Jun 30, 2009·44 cites·18 claims
- 0497US7790655B2Cell display of antibody librariesMEDIMMUNE LLC·Filed 2006·Granted Sep 7, 2010·36 cites·15 claims
- 0597US7229619B1Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2000·Granted Jun 12, 2007·114 cites·80 claims
- 0697US6656467B2Ultra high affinity neutralizing antibodiesMEDIMMUNE INC·Filed 2001·Granted Dec 2, 2003·96 cites·20 claims
- 0796US7847082B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2009·Granted Dec 7, 2010·26 cites·33 claims
- 0896US7179900B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2003·Granted Feb 20, 2007·45 cites·80 claims
- 0995US9988459B2Anti-IFNAR1 antibodies with reduced Fc ligand affinityMEDIMMUNE LLC·Filed 2017·Granted Jun 5, 2018·21 cites·2 claims
- 1095US8697396B2Modulation of antibody effector function by hinge domain engineeringDALL ACQUA WILLIAM·Filed 2011·Granted Apr 15, 2014·40 cites·10 claims
- 1195US8372403B2Humanized anti-factor D antibodies and uses thereofGENENTECH INC·Filed 2012·Granted Feb 12, 2013·17 cites·31 claims
- 1295US8309690B2Integrated approach for generating multidomain protein therapeuticsALLAN CHRISTIAN·Filed 2006·Granted Nov 13, 2012·87 cites·25 claims
- 1395US8067002B2Humanized anti-factor D antibodiesAN LING-LING·Filed 2007·Granted Nov 29, 2011·29 cites·28 claims
- 1495US7659374B2Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activityMEDIMMUNE LLC·Filed 2005·Granted Feb 9, 2010·28 cites·14 claims
- 1595US7323172B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE INC·Filed 2004·Granted Jan 29, 2008·48 cites·12 claims
- 1694US7635568B2Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatmentMEDIMMUNE LLC·Filed 2004·Granted Dec 22, 2009·39 cites·95 claims
- 1794US7354584B2Recombinant IL-9 antibodiesMEDIMMUNE INC·Filed 2004·Granted Apr 8, 2008·50 cites·9 claims
- 1893US8604171B2High affinity, anti-human IgE antibodiesSINGH SANJAYA·Filed 2012·Granted Dec 10, 2013·28 cites·12 claims
- 1993US8323653B2Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseDAMSCHRODER MELISSA·Filed 2007·Granted Dec 4, 2012·32 cites·9 claims
- 2093US8252284B2High affinity, anti-human IgE antibodiesSINGH SANJAYA·Filed 2009·Granted Aug 28, 2012·31 cites·11 claims
- 2193US8193329B2Nucleic acids encoding anti-factor D antibodiesAN LING-LING·Filed 2011·Granted Jun 5, 2012·15 cites·44 claims
- 2292US8883992B2Humanized anti-CD19 antibodiesMEDIMMUNE LLC·Filed 2012·Granted Nov 11, 2014·11 cites·9 claims
- 2392US8187604B2Methods of treating with anti-factor D antibodiesAN LING-LING·Filed 2011·Granted May 29, 2012·12 cites·39 claims
- 2492US7740851B2Ultra high affinity neutralizing antibodiesMEDIMMUNE LLC·Filed 2003·Granted Jun 22, 2010·35 cites·32 claims
- 2592US7585504B2High affinity antibodies against HMGB1 and methods of use thereofMEDIMMUNE LLC·Filed 2005·Granted Sep 8, 2009·21 cites·16 claims
- 2692US7531169B2High affinity anti-human IgE antibodiesTANOX INC·Filed 2004·Granted May 12, 2009·43 cites·17 claims
- 2791US8753826B2Methods of detecting factor D with anti-factor D antibodiesGENENTECH INC·Filed 2013·Granted Jun 17, 2014·8 cites·32 claims
- 2891US8008443B2Modulation of antibody effector function by hinge domain engineeringMEDIMMUNE LLC·Filed 2006·Granted Aug 30, 2011·25 cites·8 claims
- 2990US8153133B2High potency recombinant antibodies and method for producing themYOUNG JAMES F·Filed 2010·Granted Apr 10, 2012·20 cites·30 claims
- 3090US6531580B1Anti-αvβ3 recombinant human antibodies and nucleic acids encoding sameIXSYS INC·Filed 1999·Granted Mar 11, 2003·67 cites·49 claims
- 3190US6312693B1Antibodies against human CD40Filed 1999·Granted Nov 6, 2001·68 cites·26 claims
- 3289US7175996B1Methods of optimizing antibody variable region binding affinityAPPLIED MOLECULAR EVOLUTION·Filed 2000·Granted Feb 13, 2007·14 cites·6 claims
- 3388US8137670B2Method of identifying membrane IgE specific antibodies and use thereof for targeting IgE producing precursor cellsWU HERREN·Filed 2006·Granted Mar 20, 2012·10 cites·20 claims
- 3487US2024417460A1Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseVIELA BIO INC·Filed 2024·Application pending·0 cites
- 3586US9896505B2Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseMEDIMMUNE LLC·Filed 2014·Granted Feb 20, 2018·5 cites·8 claims
- 3686US6849425B1Methods of optimizing antibody variable region binding affinityIXSYS INC·Filed 1999·Granted Feb 1, 2005·37 cites·30 claims
- 3785US7964706B2High affinity antibodies against HMGB1 and methods of use thereofMEDIMMUNE LLC·Filed 2006·Granted Jun 21, 2011·10 cites·16 claims
- 3883US8507656B2Stabilized angiopoietin-2 antibodies and uses thereofBEDIAN VAHE·Filed 2009·Granted Aug 13, 2013·6 cites·15 claims
- 3983US2025101116A1Anti-ifnar1 antibodies with reduced fc ligand affinityASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 4082US10301390B2Anti-IFNAR1 antibodies with reduced Fc ligand affinityASTRAZENECA AB·Filed 2018·Granted May 28, 2019·2 cites·3 claims
- 4182US7371382B2Methods of inhibiting αvβ3-mediated binding with αvβ3-specific antibodiesAPPLIED MOLECULAR EVOLUTION·Filed 2002·Granted May 13, 2008·11 cites·56 claims
- 4281US8153131B2High affinity antibodies against HMGB1 and methods of use thereofWU HERREN·Filed 2009·Granted Apr 10, 2012·4 cites·18 claims
- 4379US8129130B2High affinity antibodies against HMGB1 and methods of use thereofWU HERREN·Filed 2011·Granted Mar 6, 2012·5 cites·4 claims
- 4478US8633297B2Protein scaffoldsWU HERREN·Filed 2008·Granted Jan 21, 2014·4 cites·17 claims
- 4576US9567389B2Cell display of antibody librariesMEDIMMUNE LLC·Filed 2013·Granted Feb 14, 2017·1 cites·20 claims
- 4675US8404236B2Method of identifying membrane Ig specific antibodies and use thereof for targeting immunoglobulin-producing precursor cellsWU HERREN·Filed 2012·Granted Mar 26, 2013·2 cites·17 claims
- 4773US2021061906A1Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune diseaseVIELA BIO INC·Filed 2020·Application pending·0 cites
- 4873US2020172625A1Anti-ifnar1 antibodies with reduced fc ligand affinityASTRAZENECA AB·Filed 2019·Application pending·0 cites
- 4971US8481037B2Recombinant IL-9 antibodies and uses thereofREED JENNIFER LYNNE·Filed 2011·Granted Jul 9, 2013·2 cites·16 claims
- 5069US9176129B2Protein scaffoldsMEDIMMUNE LLC·Filed 2013·Granted Nov 3, 2015·1 cites·20 claims
Showing the top 50 of 107 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Herren Wu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →